文献速递皮肤肿瘤

早期黑色素瘤侵袭性与肠道真菌及细菌谱相关

Early melanoma invasivity correlates with gut fungal and bacterial profiles.
PubMed 文献 · Br J Dermatol · 2021-10-10

本研究对I–II期黑色素瘤患者及健康对照的粪便进行细菌16S rRNA和真菌ITS测序,并与转移性黑色素瘤菌群数据做荟萃分析。发现真菌与细菌组合可区分患者与对照,且菌群与肿瘤侵袭性、消退相关;早期患者细菌群落结构不同于转移性且更丰富。

要点

  • 肠道真菌与细菌组合可区分早期黑色素瘤患者与健康对照。
  • 菌群与黑色素瘤侵袭性相关,特定真菌谱与肿瘤消退相关。
  • 早期与转移性黑色素瘤患者肠道细菌群落结构与丰富度不同。

核心结论

  • 早期黑色素瘤肠道菌群组成沿原位→侵袭→转移梯度变化,并与组织学特征及晚期免疫治疗反应相关。

研究设计与样本

  • 对I期和II期黑色素瘤患者及健康对照的粪便样本进行细菌16S rRNA和真菌ITS区域测序,并与转移性黑色素瘤菌群数据做荟萃分析。

主要发现

  • 真菌与细菌组合谱可显著区分黑色素瘤患者与对照。
  • 患者中观察到Prevotella copri和Saccharomycetales目酵母菌丰度增加。
  • 细菌与真菌群落与黑色素瘤侵袭性相关,特定真菌谱与肿瘤消退相关。
  • Bacteroides被识别为免疫原性的一般标志物,在消退性和侵袭性黑色素瘤中共享。
  • I期和II期患者细菌群落结构与转移性患者不同且更丰富。

临床怎么用

  • 肠道真菌与细菌谱有望作为早期黑色素瘤无创监测与预后评估的潜在生物标志物。
  • 菌群特征可能辅助判断肿瘤侵袭性与消退倾向,并为免疫治疗反应预测提供线索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The microbiome is emerging as a crucial player of the immune checkpoint in cancer. Melanoma is a highly immunogenic tumour, and the composition of the gut microbiome has been correlated to prognosis and evolution of advanced melanoma and proposed as a biomarker for immune checkpoint therapy. OBJECTIVES: We investigated the gut fungal and bacterial compositions in early-stage melanoma and correlated microbial profiles with histopathological features. METHODS: Sequencing of bacterial 16S rRNA and the fungal internal transcribed spacer region was performed on faecal samples of patients with stage I and II melanoma, and healthy controls. A meta-analysis with gut microbiota data from patients with metastatic melanoma was also carried out. RESULTS: We found a combination of gut fungal and bacterial profiles significantly discriminating patients with melanoma from controls. In patients with melanoma, we observed an abundance of Prevotella copri and yeasts belonging to the order Saccharomycetales. We found that the bacterial and fungal community correlated to melanoma invasiveness, whereas the specific fungal profile correlated to melanoma regression. Bacteroides was identified as general marker of immunogenicity, being shared by regressive and invasive melanoma. In addition, the bacterial communities in patients with stage I and II melanoma were different in structure and richer than those from patients with metastatic melanoma. CONCLUSIONS: The composition of the gut microbiota in early-stage melanoma changes along the gradient from in situ to invasive (and metastatic) melanoma. Changes in the microbiota and mycobiota are correlated to the histological features of early-stage melanoma, and to the clinical course and response to immune therapies of advanced-stage melanoma, through direct or indirect immunomodulation.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Vitali F, Colucci R, Di Paola M, et al. Early melanoma invasivity correlates with gut fungal and bacterial profiles. Br J Dermatol. 2021. PMID: 34227096. doi:10.1111/bjd.20626

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。